Video

In Small Stroke Patient Group TEMPO-1 Trial Shows Early Promise

Author(s):

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Shelagh Coutts, MB, ChB, from the University of Calgary discussed the results of the TEMPO-1 Trial while at the International Stroke Conference in Nashville.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.